Patent ID: 11877995
Assignee: IMMUNIC AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 29:
30. A method of treating multiple sclerosis in a subject in need thereof, the method comprising:
a) administering to the subject at least one calcium salt of 2-({3-fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid or solvate thereof each day for 7 days at an initial daily dose; and thereafter
b) administering to the subject the at least one calcium salt of 2-({3-fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid or solvate thereof at a subsequent daily dose,
wherein the initial daily dose is about 15 mg per day to about 22.5 mg per day,
wherein the subsequent daily dose is about 30 mg per day to about 45 mg per day, and
wherein the initial daily dose and the subsequent daily dose are calculated based on the weight of 2-({3-fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid.